Cite
HARVARD Citation
Schwering, C. et al. (2021). Development of the "Hamburg Best Practice Guidelines for ICV−Enzyme Replacement therapy (ERT) in CLN2 Disease" Based on 6 Years Treatment Experience in 48 Patients. Journal of child neurology. pp. 635-641. [Online].